Do Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers Decrease the Risk of Hospitalization Secondary to Community-Acquired Pneumonia? A Nested Case-Control Study
- 1 April 2006
- journal article
- clinical trial
- Published by Wiley in Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
- Vol. 26 (4) , 479-482
- https://doi.org/10.1592/phco.26.4.479
Abstract
Study Objective. As studies have shown that angiotensin‐converting enzyme (ACE) inhibitors may lower the risk of developing pneumonia by increasing the cough reflex, we sought to explore the potential association between use of ACE inhibitors and the risk of hospitalization secondary to community‐acquired pneumonia (CAP). To test this hypothesis further, we also looked at the risk for CAP in those taking angiotensin II receptor blockers (ARBs), as these drugs have a similar mechanism of action to that of ACE inhibitors but have minimal or no effect on the cough reflex. In addition, the putative protection against pneumonia may instead be related to general inhibition of the renin‐angiotensin system.Keywords
This publication has 5 references indexed in Scilit:
- The Risk for Myocardial Infarction with Cyclooxygenase-2 Inhibitors: A Population Study of Elderly AdultsAnnals of Internal Medicine, 2005
- ACE inhibitors and protection against pneumonia in elderly patients with strokeNeurology, 2005
- Angiotensin-converting enzyme inhibition in hypertensive patients is associated with a reduction in the occurrence of atrial fibrillationJournal of the American College of Cardiology, 2004
- Effects of an Angiotensin-converting Enzyme Inhibitor–based Regimen on Pneumonia RiskAmerican Journal of Respiratory and Critical Care Medicine, 2004
- Reduction of risk of pneumonia associated with use of angiotensin I converting enzyme inhibitors in elderly inpatientsAmerican Journal of Hypertension, 1999